How Much Does Vyvanse Cost On The Street?

In 2025, the stimulant drug Vyvanse is sold on the street for $3 to $30 per tablet. The price range is due to a number of different variables, such as location of sale, potency of the drug, dosage, local laws, and other factors. A person could reasonably expect to pay $10 for a 50 mg Vyvanse pill on the street.

The average cost of prescription drugs sold on the street is typically based on how easy they are to acquire, local law enforcement, location, and other considerations.

How Much Does Vyvanse Cost On The Street?

Vyvanse comes in 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg doses. The higher the milligram, the more a drug dealer can charge for the pill.

Factors That Affect Vyvanse Street Cost

Vyvanse (lisdexamfetamine) is a Schedule II stimulant medication primarily prescribed for ADHD and binge eating disorder. As a prodrug that requires metabolic conversion to become active, it was designed to have lower abuse potential than other stimulants. However, it still enters illicit markets, particularly among students and professionals seeking cognitive enhancement.

Factors affecting illicit Vyvanse prices:

• Academic Calendar Influence: prices typically spike during exam periods and the beginning of school semesters
• Dosage Strength: higher doses (50mg, 60mg, 70mg) generally command higher prices than starter doses (20mg, 30mg)
• Geographic Concentration: college towns and areas with high student populations see more consistent markets
• Tamper-Resistant Properties: cannot be effectively crushed or injected, limiting appeal to some users and affecting pricing
• Prescription Accessibility: requires specialist diagnosis for ADHD, creating a more limited legitimate supply than some other medications
• Competition From Other Stimulants: Adderall and other amphetamines may offer more immediate effects, impacting Vyvanse demand
• Professional vs Recreational Markets: different pricing for students seeking study aids versus recreational users
• Insurance Coverage Patterns: high legitimate costs can drive diversion when people can’t afford prescriptions
• Duration of Effect: longer-acting formulation appeals to some users but may limit others seeking shorter effects
• Law Enforcement Awareness: generally less targeted than opioids, potentially affecting availability

The illicit Vyvanse market reflects both its intended design features and unintended consequences. While its prodrug mechanism reduces some forms of abuse, it remains valuable in markets focused on cognitive enhancement rather than euphoria. The cyclical demand patterns tied to academic schedules highlight how prescription stimulant abuse often differs from traditional drug markets, requiring prevention approaches that address both legitimate medical needs and misuse in educational and professional settings.

Vyvanse is expensive at the pharmacy. Out-of-pocket cost, without insurance, can be upwards of $400 for a 30-day supply, or $13.33 per pill. With insurance, the cost can sometimes drop to $0.

Dangers Of Buying Vyvanse On The Street

One of the biggest concerns about buying street Vyvanse is that it’s not subject to any quality control, and counterfeit pills designed to look like Vyvanse have become increasingly common. Many counterfeit stimulant pills contain substances such as methamphetamine or fentanyl, and there is no way to tell a fake pill from a legitimate one by appearance alone. Even a single counterfeit pill containing fentanyl can be fatal for someone with no opioid tolerance.

Using Vyvanse without medical supervision means there is no oversight of dosage, potential drug interactions, or underlying health conditions that could make stimulant use dangerous. Regular misuse can lead to physical and psychological dependence, cardiovascular problems, severe anxiety, and in some cases psychosis. Possession of Vyvanse without a valid prescription is also a federal offense that can result in serious legal consequences.

To learn about substance abuse treatment programs in your area, reach out to your primary care provider or talk to an addiction specialist today.

Written by the Addiction Resource Editorial Staff